USP34 and hepatocellular carcinoma: These findings provide us with a deeper understanding of the mechanism by which USP34 inhibits the growth of HCC through aerobic glycolysis and offers theoretical and experimental support for the use of USP34 as a molecular marker for HCC diagnosis and prognosis.